Milestone Pharmaceuticals Announces Cost-Efficiency Measures To Reduce Its Opex By ~30%, Completed By Q1 2027; Expects To Incur ~$2M In One-Time Charges

Benzinga

2026.11.13 12:13 (GMT+0)

Abrir en Benzinga